A Patient with Neoplasm in the Left Leg with Lung and Brain Metastases

Dongying LIU,Xiongzhi WU,Yumin WANG,Guangru XIE,Zhuchen YAN,Zhensong YUE,Zhongyua LIU,Zhanyu PAN,Haiyan SUN

DOI: https://doi.org/10.3969/j.issn.1000-8179.2008.06.015

2008-01-01

Chinese Journal of Clinical Oncology

Abstract:Alveolar soft part sarcoma (ASPS) is a rare soft tissue tumor of uncertain histogenesis with a non-reciprocal translocation der (17) t (X;17) (p11.2; q25) leading to the fusion of the ASPL gene to the gene encoding transcription factor TEF3. ASPS is mainly found in the extremities, especially the deep soft parts of lower limbs. Histologically, the tumor shows typical alveolar and nest arrangement with eosinophilic granules or crystals in the cytoplasm of tumor cells. ASPS often occurs in young women. Although it displays a slow clinical course, it often metastasizes to the lung, bone, liver and brain, worsening the prognosis. Complete resection is critical for treatment of localized alveolar soft part sarcoma. Adjuvant chemotherapy and radiotherapy have demonstrated few benefits. Here, we present a case of primary ASPS of the left leg with lung and brain metastases in a 37-year-old woman. She underwent surgery, radiotherapy and interventional therapy. Because of the progression of metastases in her lungs she was also given immunotherapy, molecular target therapy and traditional Chinese medicine. We investigate whether the modern treatment can prolong the survival of ASPS patients.